Krystal Biotech: Revenue Increase of 473% Thanks to Gene Therapy for Severe Skin Diseases

Many genetic skin diseases lead to significant limitations in quality of life. In the context of classical pharmacy, only symptomatic treatment was possible, which alleviated pain and prevented infections but did not address the underlying cause of the disease. Gene therapies now offer the opportunity to target the genetic cause directly. Krystal Biotech benefits from the high potential demand associated with its specialization in the development of gene therapies for the treatment of rare skin diseases. In the past 20 days, the company's stock...